Table: Cosmos Pharmaceutical -2018/19 group results

Cosmos Pharmaceutical

12/07/2019 07:00

Jul 12 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2019    May 31, 2018   May 31, 2020     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          611.14          558.00         658.50        322.50   
               (+9.5 pct)      (+11.0 pct)    (+7.7 pct)    (+8.1 pct) 
  Operating       24.78           22.75          24.80         11.82   
               (+8.9 pct)      (+2.3 pct)     (+0.1 pct)    (-4.1 pct) 
  Recurring       27.29           25.26          27.30         13.07   
               (+8.1 pct)      (+2.7 pct)     (+0.0 pct)    (-3.2 pct) 
  Net
  Net             19.19           17.63          19.19          8.89   
               (+8.8 pct)      (-3.2 pct)     (+0.0 pct)    (-1.3 pct) 
  EPS          968.97 yen      890.59 yen     969.21 yen    448.85 yen 
  Ann Div      100.00 yen       90.00 yen     100.00 yen               
  -Q2 Div       45.00 yen       45.00 yen      50.00 yen               
  -Q4 Div       55.00 yen       45.00 yen      50.00 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T